期刊文献+

嗜铬细胞瘤心脏损害的临床病例分析 被引量:6

A Case Analysis of Pheochromocytoma-Induced Cardiac Damage
在线阅读 下载PDF
导出
摘要 目的:研究嗜铬细胞瘤心脏损害的临床特点。方法:回顾性分析我院10年收治的184例嗜铬细胞瘤患者中61例心脏受累病例的临床资料。结果:61例嗜铬细胞瘤患者有可疑心脏损害,占所有嗜铬细胞瘤患者的33.2%,其中确诊病例占所有嗜铬细胞瘤患者的9.2%。嗜铬细胞瘤心脏损害的临床表现包括心绞痛、心肌梗死、心肌病变、心力衰竭、心律失常、心电图和心脏超声异常改变等。结论:应重视嗜铬细胞瘤患者的心脏损害。在高血压患者合并心血管病变时,应与嗜铬细胞瘤心脏损害进行鉴别。 Objective:To explore the clinical characteristics of pheochromocytoma-induced cardiac damage. Methods :The clinical characteristics of cardiac damage induced by 184 cases of pheochromocytomas were retrospectively analyzed. Results:Sixty-one patients with pheochromocytomas were suspected to have cardiac damage, accounting for 33.2%, with the confirmed diagnosis of 9. 2% of all patients. The clinical data from the patients with cardiac damage were analyzed. The manifestations involved myocardial ischemia, myocardial infarction, myocardial changes, arrhythmia, cardiac insufficiency, and abnormal changes of electrocardiogram and echocardiography. Conclusion:Pheochromocytoma-induced cardiac damage should be taken into consideration in patients with pheochromocytomas.
出处 《中国循环杂志》 CSCD 北大核心 2006年第2期97-99,共3页 Chinese Circulation Journal
基金 国家科技攻关计划课题(2004BA720A29)
关键词 嗜铬细胞瘤 心脏损害 Pheochromocytoma Cardiac damage
  • 相关文献

参考文献8

  • 1Mirza A.Myocardial infarction resulting from nonatherosclerotic coronary artery diseases.Am J Emerg Med,2003,21 (7):578-584.
  • 2Sheikhzadeh A,Fatourechi V,Paydar D,et al.Unusual cardiovascular manifestation in a case of pheochromocytoma.Clin Cardiol,1983,6:136-142.
  • 3Attar MN,Moulik PK,Salem GD,et al.Phaeochromocytoma presenting as dilated cardiomyopathy.Int J Clin Pract,2003,57(6):547-548.
  • 4Serfas D,Shoback DM,Lorell BH.Pheochromocytoma and hypertrophic cardiomyopahty.Lancet,1983,2:711-713.
  • 5Brilakis ES,Young WF Jr,Wilson JW,et al.Reversible catecholamineinduced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension.J Heart Lung Transplant,1999,18 (4):376-380.
  • 6Gomez Ramos MJ,Gonzalez Valverde FM,Sanchez Alvarez MC.Sippie's syndrome presenting acutely as severe heart failure.Eur J Emerg Med,2002,9(2):171-174.
  • 7Imperadore F,Azzolini M,Piscioli F,et al.A rare cause of cardiogenic shock:catecholamine cardiomyopathy of pheochromocytoma.Ital Heart J,2002,3(6):375-378.
  • 8Mootha VK,Feldman J,Mannting F,et al.Pheochromocytoma-induced cardiomyopathy.Circulation,2000,102 (1):pE11-13.

同被引文献35

  • 1陈羽,陈炜,丘少鹏,陈俊星.腹腔镜手术治疗肾上腺嗜铬细胞瘤安全性评价[J].中华泌尿外科杂志,2005,26(3):154-156. 被引量:27
  • 2潘东亮,李汉忠,罗爱伦,曾正陪,李方.嗜铬细胞瘤诊治50年回顾总结[J].中华泌尿外科杂志,2005,26(11):725-727. 被引量:48
  • 3Lenders JW,Pacak K,Walther MM,et al.Biochemical diagnosis of pheochromocytoma:which test is best[J]? JAMA,2002,287:1427-1434.
  • 4Manger WM,Gifford RW.Pheochromocytoma[J].J Clin Hypertens,2002,4:62-72.
  • 5Lenz T,Gossman J,Schulte KL,et al.Diagnosis of pheochromocytoma[J].Clin Lab,2002,48:5-18.
  • 6Mundschenk J,Unger N,Schulz S,et al.Somatostatin receptor subtypes in human pheochromocytoma:subcellular expression pattern and functional relevance for octreotide scintigraphy[J].J Clin Endocrinol Metab,2003,88:5150-5157.
  • 7Salomon L,Rabi R,Soulie M,et al.Experience with retroperitoneal laparoscopic adrenalectomy for pheochromocytoma[J].J Urol,2001,165:1882-1883.
  • 8Prejbisz A, Lenders JW, Eisenhofer G, et al. Cardiovascular manifestations of phaeochromocytoma [ J ]. J Hypertens, 2011,29 : 2049-2060.
  • 9Lang RM,Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology [ J]. J Am Soc Echocardiogr, 2005,18 : 1440-1463.
  • 10Lenders JWM, Eisenhofer G, Mannelli M, et al Phaeochromocytoma [ J]. Lancet, 2005,366:665-675.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部